Inflammation and innate immunity

You have full text access to this OnlineOpen article

Involvement of the CXCL12/CXCR4 pathway in the advanced liver disease that is associated with hepatitis C virus or hepatitis B virus

  1. Ori Wald1,
  2. Orit Pappo2,
  3. Rifaat Safadi3,
  4. Michal Dagan-Berger1,
  5. Katia Beider1,
  6. Hanna Wald1,
  7. Suzanna Franitza1,
  8. Ido Weiss1,
  9. Shani Avniel1,
  10. Pal Boaz1,
  11. Jacob Hanna5,
  12. Gidi Zamir4,
  13. Ahmed Eid4,
  14. Ofer Mandelboim5,
  15. Ulrich Spengler6,
  16. Eithan Galun1,
  17. Amnon Peled1,*

Article first published online: 1 MAR 2004

DOI: 10.1002/eji.200324441

Issue

European Journal of Immunology

European Journal of Immunology

Volume 34, Issue 4, pages 1164–1174, April 2004

Additional Information

How to Cite

Wald, O., Pappo, O., Safadi, R., Dagan-Berger, M., Beider, K., Wald, H., Franitza, S., Weiss, I., Avniel, S., Boaz, P., Hanna, J., Zamir, G., Eid, A., Mandelboim, O., Spengler, U., Galun, E. and Peled, A. (2004), Involvement of the CXCL12/CXCR4 pathway in the advanced liver disease that is associated with hepatitis C virus or hepatitis B virus. Eur. J. Immunol., 34: 1164–1174. doi: 10.1002/eji.200324441

Author Information

  1. 1

    Goldyne Savad Institute of Gene Therapy, Hadassah University Hospital, Jerusalem, Israel

  2. 2

    Department of Pathology, Hadassah University Hospital, Jerusalem, Israel

  3. 3

    Liver and Gastroenterology Unit, Division of Medicine, Hadassah University Hospital, Jerusalem, Israel

  4. 4

    Department of Surgery, Hadassah University Hospital, Jerusalem, Israel

  5. 5

    Lautenberg Center for General and Tumor Immunology, Hadassah University Hospital, Jerusalem, Israel

  6. 6

    Department of Internal Medicine, University of Bonn, Bonn, Germany

*Hadassah University Hospital, Goldyne Savad Institute of Gene Therapy, P.O Box 12000, Jerusalem, Israel Fax: +972-2-6430982

Publication History

  1. Issue published online: 23 MAR 2004
  2. Article first published online: 1 MAR 2004
  3. Manuscript Accepted: 7 FEB 2004
  4. Manuscript Revised: 25 JAN 2004
  5. Manuscript Received: 11 AUG 2003

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (456K)
  • 1
    Heydtmann, M., Shields, P., McCaughan, G. and Adams, D., Cytokines and chemokines in the immune response to hepatitis C infection. Curr. Opin. Infect. Dis. 2001. 14: 279–287.
  • 2
    Doherty, D. G., Norris, S., Madrigal-Estebas, L., McEntee, G., Traynor, O., Hegarty, J. E. and O'Farrelly, C., The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J. Immunol. 1999. 163: 2314–2321.
  • 3
    Valiante, N. M., D'Andrea, A., Crotta, S., Lechner, F., Klenerman, P., Nuti, S., Wack, A. and Abrignani, S., Life, activation and death of intrahepatic lymphocytes in chronic hepatitis C. Immunol. Rev. 2000. 174: 77–89.
    Direct Link:
  • 4
    Nuti, S., Rosa, D., Valiante, N. M., Saletti, G., Caratozzolo, M., Dellabona, P., Barnaba, V. and Abrignani, S., Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Vα24+ T cells and rapid elimination of effector cells by apoptosis. Eur. J. Immunol. 1998. 28: 3448–3455.
    Direct Link:
  • 5
    Campbell, J. J. and Butcher, E. C., Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr. Opin. Immunol. 2000. 12: 336–341.
  • 6
    Shields, P. L., Morland, C. M., Salmon, M., Qin, S., Hubscher, S. G. and Adams, D. H., Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J. Immunol. 1999. 163: 6236–6243.
  • 7
    Boisvert, J., Kunkel, E. J., Campbell, J. J., Keeffe, E. B., Butcher, E. C. and Greenberg, H. B., Liver-infiltrating lymphocytes in end-stage hepatitis C virus: subsets, activation status, and chemokine receptor phenotypes. J. Hepatol. 2003. 38: 67–75.
  • 8
    Grant, A. J., Goddard, S., Ahmed-Choudhury, J., Reynolds, G., Jackson, D. G., Briskin, M., Wu, L., Hubscher, S. G. and Adams, D. H., Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. Am. J. Pathol. 2002. 160: 1445–1455.
  • 9
    Peled, A., Petit, I., Kollet, O., Magid, M., Ponomaryov, T., Byk, T., Nagler, A., Ben-Hur, H., Many, A., Shultz, L. et al., Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999. 283: 845–848.
  • 10
    Nanki, T., Hayashida, K., El-Gabalawy, H. S., Suson, S., Shi, K., Girschick, H. J., Yavuz, S. and Lipsky, P. E., Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. J. Immunol. 2000. 165: 6590–6598.
  • 11
    Buckley, C. D., Amft, N., Bradfield, P. F., Pilling, D., Ross, E., Arenzana-Seisdedos, F., Amara, A., Curnow, S. J., Lord, J. M., Scheel-Toellner, D. and Salmon, M., Persistent induction of the chemokine receptor CXCR4 by TGF-β1 on synovial T cells contributes totheir accumulation within the rheumatoid synovium. J. Immunol. 2000. 165: 3423–3429.
  • 12
    Pablos, J. L., Santiago, B., Galindo, M., Torres, C., Brehmer, M. T., Blanco, F. J. and Garcia-Lazaro, F. J., Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis. J. Immunol. 2003. 170: 2147–2152.
  • 13
    Gonzalo, J. A., Lloyd, C. M., Peled, A., Delaney, T., Coyle,A. J. and Gutierrez-Ramos, J. C., Critical involvement of the chemotactic axis CXCR4/stromal cell-derived factor-1 alpha in the inflammatory component of allergic airway disease. J. Immunol. 2000. 165: 499–508.
  • 14
    Dienes, H. P., Drebber, U. and von Both, I., Liver biopsy in hepatitis C. J. Hepatol. 1999. 31 Suppl 1: 43–46.
  • 15
    Jarmay, K., Karacsony, G., Ozsvar, Z., Nagy, I., Schaff, Z. and Lonovics, J., Histological characteristics of chronic hepatitis C in biopsy material. Orv. Hetil. 1998. 139: 1955–1960.
  • 16
    Fischer, H. P., Willsch, E., Bierhoff, E. and Pfeifer, U., Histopathologic findings in chronic hepatitis C. J. Hepatol. 1996. 24: 35–42.
  • 17
    Bigger, C. B., Brasky, K. M. and Lanford, R. E., DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J. Virol. 2001. 75: 7059–7066.
  • 18
    Patzwahl, R., Meier, V., Ramadori, G. and Mihm, S., Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization. J. Virol. 2001. 75: 1332–1338.
  • 19
    Nishioji, K., Okanoue, T., Itoh, Y., Narumi, S., Sakamoto, M., Nakamura, H., Morita, A. and Kashima, K., Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes. Clin. Exp. Immunol. 2001. 123: 271–279.
    Direct Link:
  • 20
    Itoh, Y., Morita, A., Nishioji, K., Narumi, S., Toyama, T., Daimon, Y., Nakamura, H., Kirishima, T. and Okanoue, T., Clinicalsignificance of elevated serum interferon-inducible protein-10 levels in hepatitis C virus carriers with persistently normal serum transaminase levels. J. Viral Hepat. 2001. 8: 341–348.
    Direct Link:
  • 21
    Peled, A., Grabovsky, V., Habler, L., Sandbank, J., Arenzana-Seisdedos, F., Petit, I., Ben-Hur, H., Lapidot, T. and Alon, R., The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow. J. Clin. Invest. 1999. 104: 1199–1211.
  • 22
    Cinamon, G., Shinder, V. and Alon, R., Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines. Nat. Immunol. 2001. 2: 515–522.
  • 23
    Matthys, P., Hatse, S., Vermeire, K., Wuyts, A., Bridger, G., Henson, G. W., De Clercq, E., Billiau, A. and Schols, D., AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice. J. Immunol. 2001. 167: 4686–4692.
  • 24
    Peled, A., Kollet, O., Ponomaryov, T., Petit, I., Franitza, S., Grabovsky, V., Slav, M. M., Nagler, A., Lider, O., Alon, R. et al., The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 2000. 95: 3289–3296.
  • 25
    Salazar-Mather, T. P., Orange, J. S. and Biron, C. A., Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1α (MIP-1α)-dependent pathways. J. Exp. Med. 1998.187: 1–14.
  • 26
    Mehal, W. Z., Azzaroli, F. and Crispe, I. N., Immunology of the healthy liver: old questions and new insights. Gastroenterology 2001. 120: 250–260.
  • 27
    Rossi, D. and Zlotnik, A., The biology of chemokines and their receptors. Annu. Rev. Immunol. 2000. 18: 217–242.
  • 28
    Goddard, S., Williams, A., Morland, C., Qin, S., Gladue, R., Hubscher, S. G. and Adams, D. H., Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants. Transplantation 2001. 72: 1957–1967.
  • 29
    Askari, A. T., Unzek, S., Popovic, Z. B., Goldman, C. K., Forudi, F., Kiedrowski, M., Rovner, A., Ellis, S. G., Thomas, J. D., DiCorleto, P. E. et al., Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003. 362: 697–703.
  • 30
    Petit, I., Szyper-Kravitz, M., Nagler, A., Lahav, M., Peled,A., Habler, L., Ponomaryov, T., Taichman, R. S., Arenzana-Seisdedos, F., Fujii, N. et al., G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 2002. 3: 687–694.
  • 31
    Gunn, M. D., Kyuwa, S., Tam, C., Kakiuchi, T., Matsuzawa, A., Williams, L. T. and Nakano, H., Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 1999. 189: 451–460.
  • 32
    Luther, S. A., Bidgol, A., Hargreaves, D. C., Schmidt, A., Xu, Y., Paniyadi, J., Matloubian, M. and Cyster, J. G., Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J. Immunol. 2002. 169: 424–433.
  • 33
    Mitra, P., Shibuta, K., Mathai, J., Shimoda, K., Banner, B. F., Mori, M. and Barnard, G. F., CXCR4 mRNA expression in colon, esophageal and gastric cancers and hepatitis C infected liver. Int. J. Oncol. 1999. 14: 917–925.
  • 34
    Shackel, N. A., McGuinness, P. H., Abbott, C. A., Gorrell, M. D. and McCaughan, G. W., Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression. Am. J. Pathol. 2002. 160: 641–654.
  • 35
    Bissell, D. M., Roulot, D. and George, J., Transforming growth factor beta and the liver. Hepatology 2001. 34: 859–867.
    Direct Link:
  • 36
    Brill, A., Franitza, S., Lider, O. and Hershkoviz, R., Regulation of T-cell interaction with fibronectin by transforming growth factor-beta is associated with altered Pyk2 phosphorylation. Immunology 2001. 104: 149–156.
    Direct Link:
  • 37
    Franitza, S., Kollet, O., Brill, A., Vaday, G. G., Petit, I., Lapidot, T., Alon, R. and Lider, O., TGF-β1 enhances SDF-1α-induced chemotaxis and homing of naive T cells by up-regulating CXCR4 expression and downstream cytoskeletal effector molecules. Eur. J. Immunol. 2002. 32: 193–202.
    Direct Link:
  • 38
    Beider, K., Nagler, A., Wald, O., Franitza, S., Dagan-Berger, M., Wald, H., Giladi, H., Brocke, S., Hanna, J., Mandelboim, O. et al., Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice. Blood 2003. 102: 1951–1958.
  • 39
    Sallusto, F., Kremmer, E., Palermo, B., Hoy, A., Ponath, P., Qin, S., Forster, R., Lipp, M. and Lanzavecchia, A., Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur. J. Immunol. 1999. 29: 2037–2045.
    Direct Link:
  • 40
    Esplugues, E., Sancho, D., Vega-Ramos, J., Martinez, C., Syrbe, U., Hamann, A., Engel, P., Sanchez-Madrid, F. and Lauzurica, P., Enhanced antitumor immunity in mice deficient in CD69. J. Exp. Med. 2003. 197: 1093–1106.
  • 41
    Gonzalo, J. A., Lloyd, C. M., Wen, D., Albar, J. P., Wells, T. N., Proudfoot, A., Martinez, A. C., Dorf, M., Bjerke, T., Coyle, A. J. and Gutierrez-Ramos, J. C., The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J. Exp. Med. 1998. 188: 157–167.
  • 42
    Knodell, R. G., Ishak, K. G., Black, W. C., Chen, T. S., Craig, R., Kaplowitz, N., Kiernan, T. W. and Wollman, J., Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981. 1: 431–435.
    Direct Link:
View Full Article (HTML) Get PDF (456K)